| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000041799 |
| Receipt No. | R000047718 |
| Scientific Title | Prospective Registry of Vaccination for pneumococcal infection and heart failure among the elderly chronic heart failure patients in Nagasaki (PREVENTION-HF in Nagasaki): A prospective cohort study |
| Date of disclosure of the study information | 2020/10/01 |
| Last modified on | 2022/09/12 (Ver. 3) |
| Basic information | ||
| Public title | Prospective Registry of Vaccination for pneumococcal infection and heart failure among the elderly chronic heart failure patients in Nagasaki (PREVENTION-HF in Nagasaki): A prospective cohort study | |
| Acronym | PREVENTION-HF in Nagasaki | |
| Scientific Title | Prospective Registry of Vaccination for pneumococcal infection and heart failure among the elderly chronic heart failure patients in Nagasaki (PREVENTION-HF in Nagasaki): A prospective cohort study | |
| Scientific Title:Acronym | PREVENTION-HF in Nagasaki | |
| Region |
|
|
| Condition | |||
| Condition | Chronic Heart Failure | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the association of pneumococcal vaccination and exacerbation of heart failure (HF) among elderly chronic HF patients. |
| Basic objectives2 | Others |
| Basic objectives -Others | Significance: Although pneumococcal vaccination for patients with heart failure has been recommended in various guidelines, the actual efficacy of pneumococcal vaccination has not been fully evaluated, and the pneumococcal vaccination rate is low. The present study is the first prospective cohort study to examine the relationship between pneumococcal vaccination and exacerbation of heart failure in the elderly, and if the relationship between pneumococcal vaccination and prevention of exacerbation of heart failure can be demonstrated through this study, it may help to promote pneumococcal vaccination and prevent exacerbation of heart failure in the elderly. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Death from HF in follow up and Hospitalization due to exacerbated HF in follow up |
| Key secondary outcomes | 1. bacterial pneumonia and hospitalization
2. pneumococcal pneumonia and hospitalization 3. Invasive pneumococcal pneumonia and hospitalization 4. all-cause hospitalization |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inclusion criteria
A. Age 65 and older at inclusion B. Patients who were hospitalized each hospital due to HF in previous 5years C. Those who attend an outpatient clinic of the institutions at the time of the inclusion HF is defined as the HF confirmed by two cardiologists on Framingham HF criteria |
|||
| Key exclusion criteria | Allergy for vaccine B. Patients with a ventricular assist device C. Patients who have been admitted to a hospital for treatment of HF | |||
| Target sample size | 1434 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyoto University, Graduate School of Medicine | ||||||
| Division name | Department of Preventive Services | ||||||
| Zip code | 606-8501 | ||||||
| Address | Yoshida-honmachi, Sakyo-ku ,Kyoto | ||||||
| TEL | 817532424 | ||||||
| iwami.taku.8w@kyoto-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyoto University Graduate School of Medicine | ||||||
| Division name | Department of Preventive Services | ||||||
| Zip code | 606-8501 | ||||||
| Address | Yoshida-honmachi, Sakyo-ku ,Kyoto | ||||||
| TEL | 817532424 | ||||||
| Homepage URL | |||||||
| syoshimura-ngs@umin.ac.jp | |||||||
| Sponsor | |
| Institute | Kyoto University Graduate School of Medicine, Department of preventive services |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagasaki Medical Organization |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto University Graduate School of Medicine |
| Address | Department of Preventive Services |
| Tel | 81757532431 |
| syoshimura-ngs@umin.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 佐世保中央病院(長崎県)、長崎労災病院(長崎県)、佐世保総合医療センター(長崎県)、川棚医療センター(佐賀県)、長崎医療センター(長崎県)、大村市民病院(長崎県)、長崎みなとメディカルセンター(長崎県)、長崎記念病院(長崎県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | <Name of the organization providing the information>:
1) Sasebo Chuo Hospital 2) Nagasaki Rosai Hospital 3) Sasebo City General Medical Center 4) Nagasaki Kawatana Medical Center 5) Nagasaki Medical Center 6) Omura Municipal Hospital 7) Nagasaki Minato Medical Center 8) Nagasaki Kinen Hospital <Item of information to be provided> Medical information within the scope of normal medical practice will be collected from the medical records and routine interviews. This is an observational study and no new interventions or tests will be performed. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047718 |